EU Regulatory Heads MAP Medicines Shortages Solutions
Europe’s Heads of Medicines Agencies has mapped a number of solutions that EU member states are undertaking to address the growing problem of medicines shortages in Europe.
You may also be interested in...
Industry access to real world data for regulatory and market access purposes in Asia Pacific compares poorly with the US.
Draft guidelines due out for consultation this week in Italy are expected to shed more light on what companies will have to reveal during pricing and reimbursement negotiations.
Germany is for the first time to adopt national guidelines on prescribing biologics and biosimilars in a move towards increasing biosimilar uptake.